| Item Type | Name |
|
Concept
|
Genetics, Medical
|
|
Concept
|
Pharmacology, Clinical
|
|
Concept
|
Clinical Trials, Phase I as Topic
|
|
Concept
|
Clinical Trials, Phase II as Topic
|
|
Concept
|
Decision Support Systems, Clinical
|
|
Concept
|
Early Termination of Clinical Trials
|
|
Concept
|
Clinical Medicine
|
|
Concept
|
Clinical Trials as Topic
|
|
Academic Article
|
Evaluating the activity of temsirolimus in neuroendocrine cancer.
|
|
Academic Article
|
Pharmacogenomics in early-phase oncology clinical trials: is there a sweet spot in phase II?
|
|
Academic Article
|
The 1200 patients project: creating a new medical model system for clinical implementation of pharmacogenomics.
|
|
Academic Article
|
A randomized, phase II study of pazopanib in castrate-sensitive prostate cancer: a University of Chicago Phase II Consortium/Department of Defense Prostate Cancer Clinical Trials Consortium study.
|
|
Academic Article
|
Time from prior chemotherapy enhances prognostic risk grouping in the second-line setting of advanced urothelial carcinoma: a retrospective analysis of pooled, prospective phase 2 trials.
|
|
Academic Article
|
Implementing genomic medicine in the clinic: the future is here.
|
|
Academic Article
|
Critical analysis of contemporary clinical research in muscle-invasive and metastatic urothelial cancer: a report from the Bladder Cancer Advocacy Network Clinical Trials Working Group.
|
|
Academic Article
|
Adoption of a clinical pharmacogenomics implementation program during outpatient care--initial results of the University of Chicago "1,200 Patients Project".
|
|
Academic Article
|
Clofarabine-associated acute kidney injury in patients undergoing hematopoietic stem cell transplant.
|
|
Academic Article
|
Evidence for Clinical Implementation of Pharmacogenomics in Cardiac Drugs.
|
|
Academic Article
|
Saracatinib as a metastasis inhibitor in metastatic castration-resistant prostate cancer: A University of Chicago Phase 2 Consortium and DOD/PCF Prostate Cancer Clinical Trials Consortium Study.
|
|
Academic Article
|
Disease-drug database for pharmacogenomic-based prescribing.
|
|
Academic Article
|
Spectrum of genomic alterations in FGFR3: current appraisal of the potential role of FGFR3 in advanced urothelial carcinoma.
|
|
Academic Article
|
Clinical Evaluation of Cisplatin Sensitivity of Germline Polymorphisms in Neoadjuvant Chemotherapy for Urothelial Cancer.
|
|
Academic Article
|
Patient Perceptions of Care as Influenced by a Large Institutional Pharmacogenomic Implementation Program.
|
|
Academic Article
|
Pharmacogenomics-Based Point-of-Care Clinical Decision Support Significantly Alters Drug Prescribing.
|
|
Academic Article
|
Analyzing the clinical actionability of germline pharmacogenomic findings in oncology.
|
|
Academic Article
|
Low T-cell Receptor Diversity, High Somatic Mutation Burden, and High Neoantigen Load as Predictors of Clinical Outcome in Muscle-invasive Bladder Cancer.
|
|
Academic Article
|
Simplifying the use of pharmacogenomics in clinical practice: Building the genomic prescribing system.
|
|
Academic Article
|
Breaking Down Barriers to Effective Patient Care.
|
|
Academic Article
|
Clinical utility of neuronal cells directly converted from fibroblasts of patients for neuropsychiatric disorders: studies of lysosomal storage diseases and channelopathy.
|
|
Academic Article
|
Assessment of provider-perceived barriers to clinical use of pharmacogenomics during participation in an institutional implementation study.
|
|
Academic Article
|
The ImPreSS Trial: Implementation of Point-of-Care Pharmacogenomic Decision Support in Perioperative Care.
|
|
Academic Article
|
Pharmacogenomic-Based Decision Support to Predict Adherence to Medications.
|
|
Academic Article
|
Clinical evaluation of germline polymorphisms associated with capecitabine toxicity in breast cancer: TBCRC-015.
|
|
Academic Article
|
Incorporating preemptive pharmacogenomic testing into the clinical setting.
|
|
Academic Article
|
Implementation of pharmacogenomic testing in oncology care (PhOCus): study protocol of a pragmatic, randomized clinical trial.
|
|
Academic Article
|
Appraisal and development of evidence-based clinical decision support to enable perioperative pharmacogenomic application.
|
|
Academic Article
|
Creation of a pharmacogenomics patient portal complementary to an existing institutional provider-facing clinical decision support system.
|
|
Academic Article
|
Clinically actionable genotypes for anticancer prescribing among >1500 patients with pharmacogenomic testing.
|
|
Academic Article
|
Health-related Quality of Life of Patients with Locally Advanced or Metastatic Urothelial Cancer Treated with Enfortumab Vedotin after Platinum and PD-1/PD-L1 Inhibitor Therapy: Results from Cohort 1 of the Phase 2 EV-201 Clinical Trial.
|
|
Academic Article
|
Putative Biomarkers of Clinical Benefit With Pembrolizumab in Advanced Urothelial Cancer: Results from the KEYNOTE-045 and KEYNOTE-052 Landmark Trials.
|
|
Concept
|
Clinical Decision-Making
|